{Reference Type}: Journal Article
{Title}: CTLA-4 polymorphisms and predisposition to digestive system malignancies: a meta-analysis of 31 published studies.
{Author}: Li J;Wang W;Sun Y;Zhu Y;
{Journal}: World J Surg Oncol
{Volume}: 18
{Issue}: 1
{Year}: Mar 2020 16
{Factor}: 3.253
{DOI}: 10.1186/s12957-020-1806-2
{Abstract}: <B>BACKGROUND: </B>The results of genetic association studies regarding cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) polymorphisms and digestive system malignancies were controversial. The authors designed this meta-analysis to more precisely estimate relationships between CTLA-4 polymorphisms and digestive system malignancies by pooling the results of related studies.<BR><B>METHODS: </B>The authors searched PubMed, Embase, Web of Science, and CNKI for eligible studies. Thirty-one eligible studies were pooled analyzed in this meta-analysis.<BR><B>RESULTS: </B>The pooled meta-analysis results showed that genetic distributions of rs231775, rs4553808, and rs733618 polymorphisms among patients with digestive system malignancies and controls differed significantly. Moreover, genotypic distribution differences were also observed for rs231775 polymorphism among patients with colorectal cancer/pancreatic cancer and controls, for rs4553808 and rs5742909 polymorphisms among patients with gastric cancer and controls, for rs3087243 polymorphism among patients with liver cancer and controls, and for rs733618 polymorphism among patients with colorectal cancer and controls in pooled meta-analyses.<BR><B>CONCLUSIONS: </B>This meta-analysis suggested that rs231775 polymorphism was associated with predisposition to colorectal cancer and pancreatic cancer, rs4553808 and rs5742909 polymorphisms were associated with predisposition to gastric cancer, rs3087243 polymorphism was associated with predisposition to liver cancer, and rs733618 polymorphism was associated with predisposition to colorectal cancer.